206 related articles for article (PubMed ID: 21850275)
1. Remodeling of purinergic receptor-mediated Ca2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells.
Davis FM; Kenny PA; Soo ET; van Denderen BJ; Thompson EW; Cabot PJ; Parat MO; Roberts-Thomson SJ; Monteith GR
PLoS One; 2011; 6(8):e23464. PubMed ID: 21850275
[TBL] [Abstract][Full Text] [Related]
2. Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.
Azimi I; Beilby H; Davis FM; Marcial DL; Kenny PA; Thompson EW; Roberts-Thomson SJ; Monteith GR
Mol Oncol; 2016 Jan; 10(1):166-78. PubMed ID: 26433470
[TBL] [Abstract][Full Text] [Related]
3. Non-stimulated, agonist-stimulated and store-operated Ca2+ influx in MDA-MB-468 breast cancer cells and the effect of EGF-induced EMT on calcium entry.
Davis FM; Peters AA; Grice DM; Cabot PJ; Parat MO; Roberts-Thomson SJ; Monteith GR
PLoS One; 2012; 7(5):e36923. PubMed ID: 22666335
[TBL] [Abstract][Full Text] [Related]
4. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.
Davis FM; Azimi I; Faville RA; Peters AA; Jalink K; Putney JW; Goodhill GJ; Thompson EW; Roberts-Thomson SJ; Monteith GR
Oncogene; 2014 May; 33(18):2307-16. PubMed ID: 23686305
[TBL] [Abstract][Full Text] [Related]
5. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.
Cursons J; Leuchowius KJ; Waltham M; Tomaskovic-Crook E; Foroutan M; Bracken CP; Redfern A; Crampin EJ; Street I; Davis MJ; Thompson EW
Cell Commun Signal; 2015 May; 13():26. PubMed ID: 25975820
[TBL] [Abstract][Full Text] [Related]
6. Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells.
Stewart TA; Azimi I; Brooks AJ; Thompson EW; Roberts-Thomson SJ; Monteith GR
Int J Biochem Cell Biol; 2016 Jul; 76():64-74. PubMed ID: 27163529
[TBL] [Abstract][Full Text] [Related]
7. Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells.
Tsai PC; Fu YS; Chang LS; Lin SR
Toxicon; 2016 Mar; 111():108-20. PubMed ID: 26774845
[TBL] [Abstract][Full Text] [Related]
8. A role for calcium in the regulation of ATP-binding cassette, sub-family C, member 3 (ABCC3) gene expression in a model of epidermal growth factor-mediated breast cancer epithelial-mesenchymal transition.
Stewart TA; Azimi I; Thompson EW; Roberts-Thomson SJ; Monteith GR
Biochem Biophys Res Commun; 2015 Mar; 458(3):509-514. PubMed ID: 25666946
[TBL] [Abstract][Full Text] [Related]
9. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
10. Emodin Inhibits ATP-Induced Proliferation and Migration by Suppressing P2Y Receptors in Human Lung Adenocarcinoma Cells.
Wang X; Li L; Guan R; Zhu D; Song N; Shen L
Cell Physiol Biochem; 2017; 44(4):1337-1351. PubMed ID: 29183030
[TBL] [Abstract][Full Text] [Related]
11. Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line.
Davis FM; Parsonage MT; Cabot PJ; Parat MO; Thompson EW; Roberts-Thomson SJ; Monteith GR
Cancer Cell Int; 2013 Jul; 13(1):76. PubMed ID: 23890218
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
Wendt MK; Smith JA; Schiemann WP
Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
14. Increase of intracellular Ca2+ by purinergic receptors in cultured rat lacrimal gland myoepithelial cells.
Ohtomo K; Shatos MA; Vrouvlianis J; Li D; Hodges RR; Dartt DA
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9503-15. PubMed ID: 22039237
[TBL] [Abstract][Full Text] [Related]
15. Specific N-glycan alterations are coupled in epithelial-mesenchymal transition induced by EGF in GE11 epithelial cells.
Xu Q; Qu C; Wang W; Gu J; Du Y; Song L
Cell Biol Int; 2017 Feb; 41(2):124-133. PubMed ID: 27888538
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells.
Resende RR; Britto LR; Ulrich H
Int J Dev Neurosci; 2008 Nov; 26(7):763-77. PubMed ID: 18675894
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells.
Vergara D; Valente CM; Tinelli A; Siciliano C; Lorusso V; Acierno R; Giovinazzo G; Santino A; Storelli C; Maffia M
Cancer Lett; 2011 Nov; 310(1):1-8. PubMed ID: 21794976
[TBL] [Abstract][Full Text] [Related]
18. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells.
Liu ZC; Chen XH; Song HX; Wang HS; Zhang G; Wang H; Chen DY; Fang R; Liu H; Cai SH; Du J
Cell Tissue Res; 2014 Nov; 358(2):491-502. PubMed ID: 25124796
[TBL] [Abstract][Full Text] [Related]
19. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
20. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
